Massive vaccination is very important to end the coronavirus disease 2019 (COVID-19) pandemic. This study determined the willingness to receive a COVID-19 vaccine by the university students of Bangladesh and identified their apprehension about the effectiveness and safety of COVID-19 vaccines. Students were invited to complete an online cross-sectional survey (April 3 to June 10, 2021) to explore the intention to receive a COVID-19 vaccine and other factors regarding the responsiveness of the COVID-19 vaccine. Among the 191 respondent students, 52.9% willingly agreed to receive a vaccine, where the remaining was either not decided yet (27.7%) or was not intended to get vaccinated (15.7%). The odd of getting a vaccine were only 1.15. About 83.2% of students were conscious about the severity of COVID-19 and many students responded that they are well-versed about vaccine activity (67.5%) and risk factors (66%). Among the approved vaccines, most students preferred the Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 (38.7%) and Pfizer-BioNTech COVID-19 vaccine BNT162b2 (34%). As some of the students still have lesser intent to accept vaccines, public health officials need to be more proactive to focus on vaccine safety and benefits to enhance vaccine coverage among university students of Bangladesh.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.